person · Reporting owner
Salvadori Daniel Gesua Sive
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | EVP AND GROUP PRESIDENT | February 27, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 27, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 146,377 |
Ending reported balance
After 2026-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-27 · Tax withholding · Disposed 6,615 · Balance 147,262 Row 2 · 2026-03-02 · Sale · Disposed 885 · Balance 146,377 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2016 Filed Mar 3, 2016 00:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $39.26 | $27,482.70 |
DisclosureSEC source: 0001179110-16-020732 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,973 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,649 | $39.52 | $65,168.48 |
DisclosureSEC source: 0001179110-16-020732 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,673 Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 213,470 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019887 · edgar.xml · derivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,470 Underlying: Common shares · 213,470 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,157 on 02/19/2017, 71,156 on 02/19/2018, and 71,157 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:39 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 24,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019887 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,322 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| September 28, 2015 Filed Sep 29, 2015 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 715 | $39.65 | $28,347.61 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,974 Read SEC document |
| September 28, 2015 Filed Sep 29, 2015 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $39.64 | $3,964.10 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,689 Read SEC document |
| September 26, 2015 Filed Sep 29, 2015 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,526 | $40.86 | $62,352.36 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,789 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 127,436 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003328 · edgar.xml · derivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,436 Underlying: Common shares · 127,436 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,479 on 2/20/16, 42,478 on 2/20/17, and 42,479 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 18,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003328 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,315 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 102,425 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · derivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,425 Underlying: Common shares · 102,425 shares Expires 2024-09-25 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,142 on 9/26/2015, 34,141 on 9/26/2016, and 34,142 on 9/26/2017. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,230 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 16,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,730 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.